X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (158) 158
Publication (18) 18
Conference Proceeding (5) 5
Book / eBook (4) 4
Book Review (2) 2
Newspaper Article (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (103) 103
humans (81) 81
female (66) 66
male (59) 59
adult (38) 38
middle aged (38) 38
animals (33) 33
aged (31) 31
analysis (28) 28
neurosciences (22) 22
immunology (18) 18
mice (18) 18
oncology (15) 15
research (15) 15
aged, 80 and over (14) 14
disease (14) 14
medicine & public health (14) 14
surgery (14) 14
clinical neurology (13) 13
abridged index medicus (12) 12
adolescent (12) 12
health aspects (12) 12
multidisciplinary sciences (12) 12
article (11) 11
care and treatment (11) 11
child (11) 11
risk factors (11) 11
treatment outcome (11) 11
gene expression (10) 10
retrospective studies (10) 10
cancer (9) 9
disease models, animal (9) 9
follow-up studies (9) 9
anesthesiology (8) 8
cells, cultured (8) 8
forestry (8) 8
inflammation (8) 8
mice, inbred c57bl (8) 8
neurology (8) 8
patients (8) 8
prospective studies (8) 8
research article (8) 8
usage (8) 8
brain (7) 7
diagnosis (7) 7
genetic aspects (7) 7
hematology (7) 7
medical research (7) 7
mortality (7) 7
orthopedics (7) 7
pathology (7) 7
physiological aspects (7) 7
time factors (7) 7
young adult (7) 7
alzheimers-disease (6) 6
case-control studies (6) 6
child, preschool (6) 6
children (6) 6
cohort studies (6) 6
dna methylation (6) 6
genes (6) 6
infant (6) 6
magnetic resonance imaging (6) 6
medicine (6) 6
medicine, general & internal (6) 6
mutation (6) 6
neurons (6) 6
outcomes (6) 6
pain (6) 6
phenotype (6) 6
prognosis (6) 6
risk (6) 6
rodents (6) 6
studies (6) 6
therapy (6) 6
activation (5) 5
alzheimer's disease (5) 5
animal models (5) 5
bone marrow (5) 5
clinical trials (5) 5
ecology (5) 5
environmental aspects (5) 5
heart failure (5) 5
history (5) 5
immune response (5) 5
landscape (5) 5
macrophages (5) 5
osteoarthritis (5) 5
pediatrics (5) 5
quality of life (5) 5
quality-of-life (5) 5
rats (5) 5
rehabilitation (5) 5
science (5) 5
transplantation (5) 5
age factors (4) 4
apoptosis (4) 4
autoantibodies (4) 4
autoimmunity (4) 4
biochemistry (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science, ISSN 0036-8075, 03/2012, Volume 335, Issue 6075, pp. 1503 - 1506
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 9/2011, Volume 108, Issue 36, pp. 14968 - 14973
Aggregation of amyloid-β (Aβ) as toxic oligomers and amyloid plaques within the brain appears to be the pathogenic event that initiates Alzheimer's disease... 
Receptors | Antidepressants | Neurons | Imaging | Amyloids | Physiological regulation | Alzheimers disease | Depressive disorders | Hippocampus | Vehicles | Late-life depression | Microdialysis | Selective serotonin reuptake inhibitor antidepressants | late-life depression | ALZHEIMERS-DISEASE | MULTIDISCIPLINARY SCIENCES | INTERSTITIAL FLUID | DEPRESSIVE SYMPTOMS | MILD COGNITIVE IMPAIRMENT | CEREBROSPINAL-FLUID | MUSCARINIC ACETYLCHOLINE-RECEPTORS | PITTSBURGH COMPOUND-B | REGULATED KINASE | microdialysis | IN-VIVO | PRECURSOR PROTEIN SECRETION | selective serotonin reuptake inhibitor antidepressants | Brain - diagnostic imaging | Humans | Alzheimer Disease - drug therapy | Male | Mice, Transgenic | Thiazoles - administration & dosage | Positron-Emission Tomography | Antidepressive Agents, Second-Generation - administration & dosage | Brain - metabolism | Radiography | Animals | Citalopram - administration & dosage | Signal Transduction - drug effects | Time Factors | Amyloid beta-Peptides - genetics | Serotonin - metabolism | Alzheimer Disease - metabolism | Amyloid beta-Peptides - metabolism | Female | Mice | Alzheimer Disease - diagnostic imaging | Alzheimer Disease - genetics | Aniline Compounds - administration & dosage | Drugs | Neuroimaging | Brain | Animal models | Neurodegenerative diseases | Transgenic mice | Extracellular signal-regulated kinase | Data processing | Serotonin uptake inhibitors | beta -Amyloid | Metabolism | Amyloid | Alzheimer's disease | Positron emission tomography | citalopram | Plaques | Geriatrics | Index Medicus | Biological Sciences
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 08/2011, Volume 31, Issue 31, pp. 11328 - 11337
The concentration of amyloid-beta (A beta) within the brain extracellular space is one determinant of whether the peptide will aggregate into toxic species... 
ALPHA-SECRETASE | RAT HIPPOCAMPAL-NEURONS | ALZHEIMERS-DISEASE | INTERSTITIAL FLUID | A-BETA | PRECURSOR PROTEIN | CEREBROSPINAL-FLUID | NEUROSCIENCES | METHYL-D-ASPARTATE | GENE-TRANSCRIPTION | TRANSGENIC MICE | Enzyme-Linked Immunosorbent Assay - methods | Action Potentials - genetics | Calcium - metabolism | Humans | Extracellular Space - drug effects | Receptors, N-Methyl-D-Aspartate - metabolism | Extracellular Signal-Regulated MAP Kinases - metabolism | Synapses - pathology | Serotonin - pharmacology | N-Methylaspartate - pharmacology | Dose-Response Relationship, Drug | Extracellular Space - metabolism | Synapses - metabolism | Piperidines - pharmacology | Amyloid beta-Peptides - metabolism | Egtazic Acid - analogs & derivatives | Brain Waves - drug effects | Tetrodotoxin - pharmacology | Action Potentials - drug effects | Flavones - pharmacology | Synapses - drug effects | Mice, Inbred C57BL | Enzyme Inhibitors - pharmacology | Presenilin-1 - genetics | Mice, Transgenic | Sodium Channel Blockers - pharmacology | Excitatory Amino Acid Antagonists - pharmacology | Chelating Agents - pharmacology | Mutation - genetics | Electroencephalography - methods | Piperazines - pharmacology | Amyloid beta-Protein Precursor - genetics | Animals | Egtazic Acid - pharmacology | Pregnanolone - pharmacology | Analysis of Variance | Presenilin-1 - metabolism | Mice | Index Medicus
Journal Article
Science, ISSN 0036-8075, 3/2012, Volume 335, Issue 6075, pp. 1503 - 1506
Alzheimer's disease (AD) is associated with impaired clearance of ß-amyloid (Aß) from the brain, a process normally facilitated by apolipoprotein E (apoE).... 
Receptors | Odors | REPORTS | Mice | Alzheimers disease | Behavioral neuroscience | T tests | Hippocampus | Vehicles | Neural conduction | Microglia
Journal Article
Science, ISSN 0036-8075, 03/2012, Volume 335, Issue 6075, pp. 1503 - 1506
Alzheirner's disease (AD) is associated with impaired clearance of [beta]-amyloid (A[beta]) from the brain, a process normally facilitated by apolipoprotein E... 
Physiological aspects | Research | Apolipoproteins | Alzheimer's disease | Amyloid beta-protein
Journal Article
Proceedings of the National Academy of Sciences, ISSN 0027-8424, 09/2011, Volume 108, Issue 36, pp. 14968 - 14973
microdialysis | selective serotonin reuptake inhibitor antidepressants | late-life depression 
Physiological aspects | Genetic aspects | Serotonin | Health aspects | Alzheimer's disease | Amyloid beta-protein | Human subjects | Signal transduction | Alzheimers disease | Rodents
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology
Journal Article
JOURNAL OF NEUROLOGIC PHYSICAL THERAPY, ISSN 1557-0576, 04/2016, Volume 40, Issue 2, pp. 124 - 155
Background: Uncompensated vestibular hypofunction results in postural instability, visual blurring with head movement, and subjective complaints of dizziness... 
clinical practice guideline | VIRTUAL-REALITY | DIZZINESS | RANDOMIZED CONTROLLED-TRIAL | POSTURAL CONTROL | CLINICAL NEUROLOGY | BALANCE | RECOVERY | PHYSICAL-THERAPY | REHABILITATION | OUTCOMES | peripheral vestibular hypofunction | EXERCISES | vestibular rehabilitation | DYNAMIC VISUAL-ACUITY
Journal Article